Anthem Biosciences IPO GMP: Day 1 IPO Live Updates

Anthem Biosciences IPO GMP is ₹100 as of 14th July 2025. It is a book-building IPO of 5.96 crore shares worth ₹3,395.00 crores. It is entirely a fresh issue. The issue will be listed on BSE and NSE on its tentative listing date, 21st July 2025. The IPO price band for the Anthem Biosciences IPO is set between ₹540 and ₹570 per share. Retail investors can bid for a minimum of 1 lot of 26 shares worth ₹14,820. 

Anthem Biosciences IPO GMP Grey Market Premium

As of 14th July 2025, Anthem Biosciences IPO GMP stands at ₹100 per share. Thus, the estimated listing price would be ₹670 (570+100). This indicates that the estimated listing gain in this IPO could be 17.54%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Anthem Biosciences IPO GMP updates.

Anthem Biosciences IPO Details

Explanation

Anthem Biosciences IPO: Anthem Biosciences Limited has declared an issue price band of ₹540 to ₹570 per share. With this IPO, the company allows retail investors to bid for at least 1 lot of 26 shares worth ₹14,820. The face value of Anthem Biosciences Ltd.’s share is ₹2 per share. The shares of Anthem Biosciences Limited will be listed on BSE & NSE on its tentative listing day, 21st July 2025. Scroll down to check GMP updates and Anthem Biosciences IPO reviews. 

Objectives of Anthem Biosciences IPO

Anthem Biosciences Limited will not receive any proceeds from this offer for sale and all the proceeds will be received by the selling shareholders. 

Anthem Biosciences IPO Registrar

Kfin Technologies Limited is the registrar of the Anthem Biosciences IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Anthem Biosciences IPO allotment and refund, you can contact Kfin Technologies Limited at reachus@kfintech.com or 04067162222.

Anthem Biosciences IPO Review

The Anthem Biosciences IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Anthem Biosciences Limited’s revenue rose 30.15% from ₹1,483.07 crores in March 2024 to ₹1,930.29 crores in March 2025. Moreover, the company’s PAT increased by 22.85% from ₹367.31 crores to ₹451.26 crores. Investors can analyse other relevant factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Anthem Biosciences IPO or not.

Anthem Biosciences Limited Technicals

The PE ratio of Anthem Biosciences Limited shares is 70.62, and its Earnings Per Share (EPS) stands at 8.07. Thus, the Anthem Biosciences IPO can potentially deliver gains on its tentative listing date, 21st July 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Anthem Biosciences Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Anthem Biosciences Limited Peer Comparison

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

FAQs on Anthem Biosciences IPO

What is Anthem Biosciences IPO GMP?

Ans. Currently, on 14th July 2025, Anthem Biosciences IPO GMP (Grey Market Premium) stands at ₹100 (17.54% up). This indicates that the estimated listing price could be ₹670 per share.

What is the issue price of Anthem Biosciences IPO?

Ans. Anthem Biosciences IPO price band has been set between ₹540 to ₹570 per share. Retail investors can apply for a minimum of 1 lots consisting of 26 shares worth ₹14,820. Moreover, HNIs are required to bid for a minimum of 14 lots (364 shares) worth ₹2,07,480. 

Also Read : Asston Pharmaceuticals IPO GMP: Day 1 IPO Live Updates

Who is the registrar of the Anthem Biosciences IPO?

Ans. Kfin Technologies Limited is the registrar of the Anthem Biosciences IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding the Anthem Biosciences IPO allotment and refund, you can contact Kfin Technologies Limited at reachus@kfintech.com or 04067162222.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Anthem Biosciences IPO, download the Anthem Biosciences IPO RHP and Anthem Biosciences IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

DMart Gears Up for Q1 Reveal on 11th July; Check Key Expectations Here

Spunweb Nonwoven IPO GMP & Review: Apply or Avoid?

Anthem Biosciences IPO GMP & Review: Apply or Avoid?

List of Upcoming IPOs in 2025: Get Upcoming IPO Calendar

Meesho Filed DRHP With SEBI For IPO: Check Key Insights

Jio IPO Details: Everything You Should Know About